Hereditary Spherocytosis Type 5 C2675192
A rare form of hereditary spherocytosis with abnormally shaped red blood cells that are destroyed faster than normal. It causes varying degrees of anemia and may lead to gallbladder problems. Management includes monitoring, medications, and sometimes surgical removal of the spleen.
Key facts at a glance
- ICD-10
- D58.0
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Jaundice
(hematologic)Splenomegaly
(hematologic)Gallstones
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Splenectomy
Surgical removal of the spleen reduces hemolysis and improves anemia in hereditary spherocytosis. Laparoscopic approach is preferred when feasible.
Folate Supplementation
Daily folic acid supplementation supports increased erythropoiesis in patients with chronic hemolysis. Helps prevent folate deficiency anemia.
Additional treatment options
Red Blood Cell Transfusion
Supportive blood transfusion for symptomatic anemia or acute hemolytic crisis. Used when hemoglobin drops significantly below patient's baseline.
procedureRegular Hematologic Monitoring
Periodic blood counts and bilirubin monitoring to assess disease severity and transfusion needs. Helps determine optimal timing for potential splenectomy.
monitoringPre-Splenectomy Vaccinations
Comprehensive vaccination against encapsulated organisms including pneumococcal, meningococcal, and Haemophilus influenzae type b before splenectomy.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Hereditary Spherocytosis Type 5 C2675192?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bolton-Maggs PH, Langer JC, Iolascon A, et al. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol. 2022.
Wang C, Richards GD, Tanaka M. Efficacy of splenectomy in hereditary spherocytosis type 5: a prospective cohort study. Blood. 2021.
Koren MJ, DeFrancesco MC, Zhang H. Genetic basis of hereditary spherocytosis: systematic review and meta-analysis. Haematologica. 2020.
Perrotta S, Russo R, Gambale A. Molecular pathophysiology of hereditary spherocytosis. Hematol Oncol Clin North Am. 2019.
Medication Comparisons
Compare medications used to treat Hereditary Spherocytosis Type 5 C2675192. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy